Northern Trust
KYTH

Northern Trust’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Northern Trust’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-266,450
Closed -$20M – 4395
2015
Q3 		$20M Buy
266,450
+41,619
+19% +$3.11M 0.01% 1494
2015
Q2 		$16.9M Buy
224,831
+24,318
+12% +$1.3M 0.01% 1715
2015
Q1 		$10.1M Buy
200,513
+7,200
+4% +$302K ﹤0.01% 2078
2014
Q4 		$6.7M Sell
193,313
-5,349
-3% -$187K ﹤0.01% 2311
2014
Q3 		$6.51M Buy
198,662
+48,957
+33% +$1.72M ﹤0.01% 2337
2014
Q2 		$5.74M Sell
149,705
-10,333
-6% -$361K ﹤0.01% 2420
2014
Q1 		$6.36M Sell
160,038
-13,040
-8% -$583K ﹤0.01% 2407
2013
Q4 		$6.46M Buy
173,078
+31,303
+22% +$1.3M ﹤0.01% 2382
2013
Q3 		$6.46M Buy
141,775
+48,866
+53% +$1.46M ﹤0.01% 2330
2013
Q2 		$2.51M Buy
+92,909
New +$2.13M ﹤0.01% 2836

Northern Trust's KYTH Position: Q4 2015 in Review

Northern Trust sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 266,450 shares — an estimated $20M sold.

Northern Trust first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $20M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Northern Trust reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Northern Trust sold 266,450 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $20M.
  • Northern Trust first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Northern Trust's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $20M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Northern Trust's 13F filing for Q4 2015, filed 12 Feb 2016.